

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | production of molecular mediator involved in inflammatory response (GO:0002532) | 6.87440623 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.93036523 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.58007038 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.58007038 |
| 5 | detection of molecule of bacterial origin (GO:0032490) | 5.22218987 |
| 6 | cellular extravasation (GO:0045123) | 4.94147295 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.81319342 |
| 8 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.60989570 |
| 9 | detection of external biotic stimulus (GO:0098581) | 4.40398069 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.26496171 |
| 11 | negative regulation of interleukin-12 production (GO:0032695) | 4.10862966 |
| 12 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.00763154 |
| 13 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.00472638 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.97172413 |
| 15 | detection of biotic stimulus (GO:0009595) | 3.89696812 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.89515098 |
| 17 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.88315266 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.83819687 |
| 19 | microglial cell activation (GO:0001774) | 3.81295763 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.63005760 |
| 21 | activated T cell proliferation (GO:0050798) | 3.60383353 |
| 22 | negative regulation of T cell mediated immunity (GO:0002710) | 3.58513161 |
| 23 | leukocyte aggregation (GO:0070486) | 3.57256329 |
| 24 | respiratory burst (GO:0045730) | 3.55318561 |
| 25 | nerve growth factor signaling pathway (GO:0038180) | 3.53666327 |
| 26 | myeloid leukocyte mediated immunity (GO:0002444) | 3.49034754 |
| 27 | B cell receptor signaling pathway (GO:0050853) | 3.44310837 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.43824893 |
| 29 | response to interleukin-15 (GO:0070672) | 3.39819880 |
| 30 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.39209408 |
| 31 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.36795450 |
| 32 | positive regulation of mast cell activation (GO:0033005) | 3.34709368 |
| 33 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.32222967 |
| 34 | regulation of phospholipase A2 activity (GO:0032429) | 3.25162530 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.24471988 |
| 36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.24471988 |
| 37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.24471988 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 3.24471988 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 3.24471988 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 3.24471988 |
| 41 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.22691733 |
| 42 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.16640252 |
| 43 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.14992230 |
| 44 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.12477147 |
| 45 | ceramide catabolic process (GO:0046514) | 3.12142224 |
| 46 | regulation of tolerance induction (GO:0002643) | 3.07154916 |
| 47 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.06557834 |
| 48 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.06257002 |
| 49 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.06257002 |
| 50 | response to muramyl dipeptide (GO:0032495) | 3.05756664 |
| 51 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05347143 |
| 52 | negative thymic T cell selection (GO:0045060) | 3.03763941 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.00723377 |
| 54 | negative T cell selection (GO:0043383) | 3.00357896 |
| 55 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.00341207 |
| 56 | establishment of skin barrier (GO:0061436) | 2.99598775 |
| 57 | regulation of B cell differentiation (GO:0045577) | 2.99513107 |
| 58 | cellular response to interleukin-15 (GO:0071350) | 2.98883671 |
| 59 | positive T cell selection (GO:0043368) | 2.98828088 |
| 60 | dendritic cell migration (GO:0036336) | 2.98234297 |
| 61 | positive regulation of B cell differentiation (GO:0045579) | 2.93958798 |
| 62 | positive thymic T cell selection (GO:0045059) | 2.92744105 |
| 63 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.92250002 |
| 64 | negative regulation of adaptive immune response (GO:0002820) | 2.89709351 |
| 65 | startle response (GO:0001964) | 2.89382150 |
| 66 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.89297853 |
| 67 | glycosphingolipid catabolic process (GO:0046479) | 2.89247767 |
| 68 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.88899210 |
| 69 | regulation of leukocyte degranulation (GO:0043300) | 2.88636023 |
| 70 | immunoglobulin mediated immune response (GO:0016064) | 2.88409723 |
| 71 | negative regulation of B cell mediated immunity (GO:0002713) | 2.88040136 |
| 72 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.88040136 |
| 73 | positive regulation of tolerance induction (GO:0002645) | 2.87346998 |
| 74 | postsynaptic membrane organization (GO:0001941) | 2.85982801 |
| 75 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84621847 |
| 76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.83234017 |
| 77 | positive regulation of mast cell degranulation (GO:0043306) | 2.83234017 |
| 78 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.83052228 |
| 79 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.79210998 |
| 80 | eosinophil chemotaxis (GO:0048245) | 2.78729711 |
| 81 | defense response to protozoan (GO:0042832) | 2.76462039 |
| 82 | regulation of macrophage cytokine production (GO:0010935) | 2.76061726 |
| 83 | leukocyte degranulation (GO:0043299) | 2.75444320 |
| 84 | regulation of T cell tolerance induction (GO:0002664) | 2.75428356 |
| 85 | neutrophil chemotaxis (GO:0030593) | 2.75339085 |
| 86 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.73871063 |
| 87 | hemidesmosome assembly (GO:0031581) | 2.71920732 |
| 88 | response to peptidoglycan (GO:0032494) | 2.71750834 |
| 89 | G-protein coupled receptor internalization (GO:0002031) | 2.71623564 |
| 90 | superoxide anion generation (GO:0042554) | 2.69595161 |
| 91 | presynaptic membrane assembly (GO:0097105) | 2.69476782 |
| 92 | neutrophil migration (GO:1990266) | 2.68141310 |
| 93 | glycolipid catabolic process (GO:0019377) | 2.66810271 |
| 94 | regulation of cellular amide metabolic process (GO:0034248) | 2.65892751 |
| 95 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.64420044 |
| 96 | I-kappaB phosphorylation (GO:0007252) | 2.63952527 |
| 97 | cAMP catabolic process (GO:0006198) | 2.62548100 |
| 98 | response to host immune response (GO:0052572) | 2.60211326 |
| 99 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.60211326 |
| 100 | negative regulation of mast cell activation (GO:0033004) | 2.58914910 |
| 101 | macrophage activation involved in immune response (GO:0002281) | 2.58366179 |
| 102 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.55518945 |
| 103 | negative regulation of dendrite development (GO:2000171) | 2.53132498 |
| 104 | detection of other organism (GO:0098543) | 2.50129145 |
| 105 | sphingolipid catabolic process (GO:0030149) | 2.49851483 |
| 106 | eosinophil migration (GO:0072677) | 2.49037558 |
| 107 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.47134881 |
| 108 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.46199646 |
| 109 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.45342563 |
| 110 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.44436689 |
| 111 | neuron cell-cell adhesion (GO:0007158) | 2.42645649 |
| 112 | regulation of water loss via skin (GO:0033561) | 2.40564252 |
| 113 | regulation of mast cell activation (GO:0033003) | 2.40164813 |
| 114 | glutamate receptor signaling pathway (GO:0007215) | 2.40036107 |
| 115 | cyclic nucleotide catabolic process (GO:0009214) | 2.39915745 |
| 116 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.39705526 |
| 117 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.39454215 |
| 118 | pharyngeal system development (GO:0060037) | 2.37158219 |
| 119 | macrophage activation (GO:0042116) | 2.36397145 |
| 120 | neutrophil mediated immunity (GO:0002446) | 2.31978417 |
| 121 | positive regulation of respiratory burst (GO:0060267) | 2.30101444 |
| 122 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.30053733 |
| 123 | regulation of germinal center formation (GO:0002634) | 2.29357949 |
| 124 | dendritic spine morphogenesis (GO:0060997) | 2.29342083 |
| 125 | germinal center formation (GO:0002467) | 2.28709846 |
| 126 | regulation of platelet aggregation (GO:0090330) | 2.28641047 |
| 127 | keratinocyte development (GO:0003334) | 2.28540830 |
| 128 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.27782633 |
| 129 | positive regulation of antigen processing and presentation (GO:0002579) | 2.26718256 |
| 130 | membrane lipid catabolic process (GO:0046466) | 2.26475384 |
| 131 | autophagic vacuole fusion (GO:0000046) | 2.23527869 |
| 132 | limb bud formation (GO:0060174) | 2.23141471 |
| 133 | detection of bacterium (GO:0016045) | 2.22871656 |
| 134 | neutrophil activation (GO:0042119) | 2.22318758 |
| 135 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.21489638 |
| 136 | synaptic transmission, glutamatergic (GO:0035249) | 2.20669475 |
| 137 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.18844332 |
| 138 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.18625525 |
| 139 | response to host (GO:0075136) | 2.18306299 |
| 140 | response to host defenses (GO:0052200) | 2.18306299 |
| 141 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.18306299 |
| 142 | purinergic receptor signaling pathway (GO:0035587) | 2.18153022 |
| 143 | mitotic cell cycle arrest (GO:0071850) | 2.17503963 |
| 144 | presynaptic membrane organization (GO:0097090) | 2.17254646 |
| 145 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.16976448 |
| 146 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.15130584 |
| 147 | neutrophil activation involved in immune response (GO:0002283) | 2.12099609 |
| 148 | organelle membrane fusion (GO:0090174) | 2.11949198 |
| 149 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.11816568 |
| 150 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.10505452 |
| 151 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.09717430 |
| 152 | regulation of timing of cell differentiation (GO:0048505) | 2.09258355 |
| 153 | regulation of vesicle fusion (GO:0031338) | 2.08833479 |
| 154 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.08729948 |
| 155 | granulocyte activation (GO:0036230) | 2.07822509 |
| 156 | histone H3-K4 trimethylation (GO:0080182) | 2.07791257 |
| 157 | Rac protein signal transduction (GO:0016601) | 2.07427907 |
| 158 | sympathetic nervous system development (GO:0048485) | 2.06816992 |
| 159 | vocalization behavior (GO:0071625) | 2.06514973 |
| 160 | regulation of mast cell degranulation (GO:0043304) | 2.05538413 |
| 161 | oligosaccharide catabolic process (GO:0009313) | 2.04680785 |
| 162 | central nervous system neuron axonogenesis (GO:0021955) | 2.04586650 |
| 163 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.04517342 |
| 164 | lipoxygenase pathway (GO:0019372) | 2.03613810 |
| 165 | positive regulation of vesicle fusion (GO:0031340) | 2.02228714 |
| 166 | keratinocyte proliferation (GO:0043616) | 2.01373206 |
| 167 | pigmentation (GO:0043473) | 1.99043819 |
| 168 | myeloid cell activation involved in immune response (GO:0002275) | 1.98164286 |
| 169 | desmosome organization (GO:0002934) | 1.98012022 |
| 170 | glucosamine-containing compound catabolic process (GO:1901072) | 1.97691360 |
| 171 | energy homeostasis (GO:0097009) | 1.97083457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.83866914 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.69115816 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.63686626 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97109250 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81660569 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80599563 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.80047480 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.77842633 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70194760 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.39683651 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.38032494 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.31279288 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23084340 |
| 14 | SPI1_23127762_ChIP-Seq_K562_Human | 2.21471111 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.20470280 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.20232826 |
| 17 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.16731122 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.14721139 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06946513 |
| 20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.04274617 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.02577229 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.00807916 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.99644859 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97310116 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.95231167 |
| 26 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.93347784 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93104127 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.92101448 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89917701 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.89140468 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85130798 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84734074 |
| 33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82491341 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80248492 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.74426870 |
| 36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.74254638 |
| 37 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.74254638 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.71492970 |
| 39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71284648 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.70460349 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.69368784 |
| 42 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.68123973 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.67519944 |
| 44 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.66423549 |
| 45 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.65554003 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63264037 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.62558073 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62458586 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.62085257 |
| 50 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.59123862 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.51818345 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.48637670 |
| 53 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48429569 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47060810 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44697129 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.43885595 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42992693 |
| 58 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.42292334 |
| 59 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42292334 |
| 60 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42010718 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40714763 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39582138 |
| 63 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.38345785 |
| 64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37656617 |
| 65 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.36770451 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.36670774 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36436380 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35118574 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35011382 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34121601 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33066505 |
| 72 | MAF_26560356_Chip-Seq_TH1_Human | 1.32543784 |
| 73 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.32515788 |
| 74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32012257 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31521764 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.30652968 |
| 77 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30578676 |
| 78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30211736 |
| 79 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30208173 |
| 80 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.30054337 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29929099 |
| 82 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29927622 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29692279 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28699641 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28692767 |
| 86 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28423787 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27459516 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27058297 |
| 89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26945410 |
| 90 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.26725284 |
| 91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25077556 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24839514 |
| 93 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.24303661 |
| 94 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.23617530 |
| 95 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23557443 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22956474 |
| 97 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22718108 |
| 98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22650601 |
| 99 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.22265764 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21869817 |
| 101 | UTX_26944678_Chip-Seq_JUKART_Human | 1.20922170 |
| 102 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20300270 |
| 103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20238786 |
| 104 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19906967 |
| 105 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19399852 |
| 106 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19137233 |
| 107 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.18482604 |
| 108 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17528863 |
| 109 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16220974 |
| 110 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16020420 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13757852 |
| 112 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13540193 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11966994 |
| 114 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10457793 |
| 115 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10348915 |
| 116 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09920317 |
| 117 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09849965 |
| 118 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.09799267 |
| 119 | VDR_22108803_ChIP-Seq_LS180_Human | 1.09611934 |
| 120 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08467998 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08199914 |
| 122 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06039374 |
| 123 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05861224 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05225554 |
| 125 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04819532 |
| 126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04644789 |
| 127 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04107475 |
| 128 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04097570 |
| 129 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03275416 |
| 130 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02888145 |
| 131 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02611896 |
| 132 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02596850 |
| 133 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02435387 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02179849 |
| 135 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01736366 |
| 136 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01349844 |
| 137 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01102405 |
| 138 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00659726 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00543689 |
| 140 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00541652 |
| 141 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00139285 |
| 142 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99573273 |
| 143 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98982584 |
| 144 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98959031 |
| 145 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98916676 |
| 146 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98785587 |
| 147 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98410260 |
| 148 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97388889 |
| 149 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96956879 |
| 150 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.96892457 |
| 151 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96162877 |
| 152 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95921538 |
| 153 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.95917578 |
| 154 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.95535925 |
| 155 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94132582 |
| 156 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93807052 |
| 157 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.93524788 |
| 158 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93463728 |
| 159 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.92740456 |
| 160 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.91406890 |
| 161 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88641632 |
| 162 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87775989 |
| 163 | MYC_22102868_ChIP-Seq_BL_Human | 0.86973494 |
| 164 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86092763 |
| 165 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85887410 |
| 166 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85167912 |
| 167 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83356388 |
| 168 | MAF_26560356_Chip-Seq_TH2_Human | 0.82950689 |
| 169 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81273079 |
| 170 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.79231566 |
| 171 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.77807804 |
| 172 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.75954510 |
| 173 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75787446 |
| 174 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.72890012 |
| 175 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72726152 |
| 176 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.70556534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.46133201 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.20173113 |
| 3 | MP0003303_peritoneal_inflammation | 3.65592900 |
| 4 | MP0004381_abnormal_hair_follicle | 2.77884593 |
| 5 | MP0003880_abnormal_central_pattern | 2.68942273 |
| 6 | MP0004883_abnormal_blood_vessel | 2.61284533 |
| 7 | MP0001800_abnormal_humoral_immune | 2.58670575 |
| 8 | MP0001188_hyperpigmentation | 2.58492861 |
| 9 | MP0000685_abnormal_immune_system | 2.48746983 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.47135032 |
| 11 | MP0005409_darkened_coat_color | 2.42774579 |
| 12 | MP0002277_abnormal_respiratory_mucosa | 2.34425155 |
| 13 | MP0009785_altered_susceptibility_to | 2.32681274 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.29817567 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.24866793 |
| 16 | MP0001819_abnormal_immune_cell | 2.22962781 |
| 17 | MP0000383_abnormal_hair_follicle | 2.22181746 |
| 18 | MP0005174_abnormal_tail_pigmentation | 2.09053522 |
| 19 | MP0002254_reproductive_system_inflammat | 2.07273141 |
| 20 | MP0002405_respiratory_system_inflammati | 2.03551963 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.00206395 |
| 22 | MP0003300_gastrointestinal_ulcer | 1.94944238 |
| 23 | MP0005423_abnormal_somatic_nervous | 1.93033249 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.84327318 |
| 25 | MP0002396_abnormal_hematopoietic_system | 1.80806861 |
| 26 | MP0002102_abnormal_ear_morphology | 1.80394293 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.77063198 |
| 28 | MP0001984_abnormal_olfaction | 1.74031089 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.73359245 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.70672002 |
| 31 | MP0005164_abnormal_response_to | 1.70021918 |
| 32 | MP0008260_abnormal_autophagy | 1.67853532 |
| 33 | MP0000716_abnormal_immune_system | 1.67837894 |
| 34 | MP0002398_abnormal_bone_marrow | 1.67110099 |
| 35 | MP0009046_muscle_twitch | 1.64839406 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.63342750 |
| 37 | MP0004782_abnormal_surfactant_physiolog | 1.62489661 |
| 38 | MP0003941_abnormal_skin_development | 1.62310856 |
| 39 | MP0001486_abnormal_startle_reflex | 1.61416587 |
| 40 | MP0003635_abnormal_synaptic_transmissio | 1.57368120 |
| 41 | MP0009745_abnormal_behavioral_response | 1.56748679 |
| 42 | MP0000015_abnormal_ear_pigmentation | 1.55169688 |
| 43 | MP0005310_abnormal_salivary_gland | 1.54746024 |
| 44 | MP0005551_abnormal_eye_electrophysiolog | 1.54029300 |
| 45 | MP0004147_increased_porphyrin_level | 1.51859488 |
| 46 | MP0010678_abnormal_skin_adnexa | 1.51690137 |
| 47 | MP0004859_abnormal_synaptic_plasticity | 1.51336608 |
| 48 | MP0002090_abnormal_vision | 1.51207491 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.46881882 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.42323758 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.39386916 |
| 52 | MP0003136_yellow_coat_color | 1.39167262 |
| 53 | MP0002009_preneoplasia | 1.39023007 |
| 54 | MP0010386_abnormal_urinary_bladder | 1.38408493 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.37640177 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.37306462 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.37306462 |
| 58 | MP0002722_abnormal_immune_system | 1.37264279 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.36623105 |
| 60 | MP0002572_abnormal_emotion/affect_behav | 1.36496176 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.36388371 |
| 62 | MP0000647_abnormal_sebaceous_gland | 1.36219358 |
| 63 | MP0003690_abnormal_glial_cell | 1.35941228 |
| 64 | MP0009379_abnormal_foot_pigmentation | 1.35198645 |
| 65 | MP0002132_abnormal_respiratory_system | 1.35034427 |
| 66 | MP0005379_endocrine/exocrine_gland_phen | 1.34880883 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.33958463 |
| 68 | MP0003787_abnormal_imprinting | 1.33427377 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.31812522 |
| 70 | MP0003866_abnormal_defecation | 1.31060771 |
| 71 | MP0005464_abnormal_platelet_physiology | 1.29793252 |
| 72 | MP0009764_decreased_sensitivity_to | 1.29019672 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.28645854 |
| 74 | MP0004510_myositis | 1.28299103 |
| 75 | MP0002557_abnormal_social/conspecific_i | 1.26845497 |
| 76 | MP0002064_seizures | 1.25430449 |
| 77 | MP0004130_abnormal_muscle_cell | 1.23864500 |
| 78 | MP0002419_abnormal_innate_immunity | 1.23842936 |
| 79 | MP0002063_abnormal_learning/memory/cond | 1.22982796 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.22094906 |
| 81 | MP0002095_abnormal_skin_pigmentation | 1.21108350 |
| 82 | MP0002429_abnormal_blood_cell | 1.19712798 |
| 83 | MP0001968_abnormal_touch/_nociception | 1.18966090 |
| 84 | MP0001502_abnormal_circadian_rhythm | 1.18622800 |
| 85 | MP0002067_abnormal_sensory_capabilities | 1.18370466 |
| 86 | MP0005387_immune_system_phenotype | 1.17453092 |
| 87 | MP0001790_abnormal_immune_system | 1.17453092 |
| 88 | MP0000538_abnormal_urinary_bladder | 1.16052722 |
| 89 | MP0002876_abnormal_thyroid_physiology | 1.15819680 |
| 90 | MP0002998_abnormal_bone_remodeling | 1.14160950 |
| 91 | MP0004947_skin_inflammation | 1.12814409 |
| 92 | MP0002796_impaired_skin_barrier | 1.12674023 |
| 93 | MP0002638_abnormal_pupillary_reflex | 1.12116393 |
| 94 | MP0001346_abnormal_lacrimal_gland | 1.11716827 |
| 95 | MP0008469_abnormal_protein_level | 1.10594735 |
| 96 | MP0004484_altered_response_of | 1.10383119 |
| 97 | MP0000858_altered_metastatic_potential | 1.08984079 |
| 98 | MP0000778_abnormal_nervous_system | 1.08806121 |
| 99 | MP0006276_abnormal_autonomic_nervous | 1.06382531 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 1.05504666 |
| 101 | MP0004742_abnormal_vestibular_system | 1.05068791 |
| 102 | MP0003828_pulmonary_edema | 1.03741899 |
| 103 | MP0005671_abnormal_response_to | 1.02474271 |
| 104 | MP0002272_abnormal_nervous_system | 1.01847753 |
| 105 | MP0002735_abnormal_chemical_nociception | 1.01120017 |
| 106 | MP0001440_abnormal_grooming_behavior | 1.00634455 |
| 107 | MP0001986_abnormal_taste_sensitivity | 1.00300168 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.98963866 |
| 109 | MP0002133_abnormal_respiratory_system | 0.98021729 |
| 110 | MP0005388_respiratory_system_phenotype | 0.98021729 |
| 111 | MP0002184_abnormal_innervation | 0.97728989 |
| 112 | MP0001324_abnormal_eye_pigmentation | 0.93976177 |
| 113 | MP0008995_early_reproductive_senescence | 0.92850863 |
| 114 | MP0005410_abnormal_fertilization | 0.92425633 |
| 115 | MP0003191_abnormal_cellular_cholesterol | 0.91925574 |
| 116 | MP0002452_abnormal_antigen_presenting | 0.91125991 |
| 117 | MP0002734_abnormal_mechanical_nocicepti | 0.90579557 |
| 118 | MP0002098_abnormal_vibrissa_morphology | 0.90557165 |
| 119 | MP0005000_abnormal_immune_tolerance | 0.90281704 |
| 120 | MP0003075_altered_response_to | 0.89688919 |
| 121 | MP0006082_CNS_inflammation | 0.88117179 |
| 122 | MP0002736_abnormal_nociception_after | 0.87988633 |
| 123 | MP0005451_abnormal_body_composition | 0.86446870 |
| 124 | MP0004084_abnormal_cardiac_muscle | 0.86154884 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.85420500 |
| 126 | MP0000427_abnormal_hair_cycle | 0.85226244 |
| 127 | MP0001905_abnormal_dopamine_level | 0.84314952 |
| 128 | MP0009278_abnormal_bone_marrow | 0.84225548 |
| 129 | MP0002006_tumorigenesis | 0.83830252 |
| 130 | MP0003436_decreased_susceptibility_to | 0.82643818 |
| 131 | MP0002177_abnormal_outer_ear | 0.81829711 |
| 132 | MP0001853_heart_inflammation | 0.81377933 |
| 133 | MP0004808_abnormal_hematopoietic_stem | 0.80296349 |
| 134 | MP0005253_abnormal_eye_physiology | 0.79873745 |
| 135 | MP0000249_abnormal_blood_vessel | 0.78886927 |
| 136 | MP0000681_abnormal_thyroid_gland | 0.78831804 |
| 137 | MP0003045_fibrosis | 0.78364977 |
| 138 | MP0008004_abnormal_stomach_pH | 0.78088044 |
| 139 | MP0006072_abnormal_retinal_apoptosis | 0.77203237 |
| 140 | MP0001177_atelectasis | 0.76536458 |
| 141 | MP0005025_abnormal_response_to | 0.76379871 |
| 142 | MP0000604_amyloidosis | 0.75731401 |
| 143 | MP0002163_abnormal_gland_morphology | 0.75659757 |
| 144 | MP0001958_emphysema | 0.75576927 |
| 145 | MP0005166_decreased_susceptibility_to | 0.75328387 |
| 146 | MP0002723_abnormal_immune_serum | 0.73815458 |
| 147 | MP0001970_abnormal_pain_threshold | 0.72886594 |
| 148 | MP0003091_abnormal_cell_migration | 0.72760528 |
| 149 | MP0004019_abnormal_vitamin_homeostasis | 0.71766485 |
| 150 | MP0001851_eye_inflammation | 0.71745876 |
| 151 | MP0005647_abnormal_sex_gland | 0.71714244 |
| 152 | MP0010630_abnormal_cardiac_muscle | 0.69802602 |
| 153 | MP0005376_homeostasis/metabolism_phenot | 0.67489888 |
| 154 | MP0006054_spinal_hemorrhage | 0.66389775 |
| 155 | MP0009763_increased_sensitivity_to | 0.65281081 |
| 156 | MP0001663_abnormal_digestive_system | 0.65045618 |
| 157 | MP0003448_altered_tumor_morphology | 0.63160587 |
| 158 | MP0005390_skeleton_phenotype | 0.58746093 |
| 159 | MP0002928_abnormal_bile_duct | 0.57745582 |
| 160 | MP0001849_ear_inflammation | 0.53180569 |
| 161 | MP0009765_abnormal_xenobiotic_induced | 0.52899867 |
| 162 | MP0002933_joint_inflammation | 0.52439089 |
| 163 | MP0005076_abnormal_cell_differentiation | 0.51195594 |
| 164 | MP0000749_muscle_degeneration | 0.50352840 |
| 165 | MP0000371_diluted_coat_color | 0.49590469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 4.33870977 |
| 2 | Stomatitis (HP:0010280) | 4.20642595 |
| 3 | Abnormality of secondary sexual hair (HP:0009888) | 4.07717299 |
| 4 | Abnormality of the axillary hair (HP:0100134) | 4.07717299 |
| 5 | Absent/shortened dynein arms (HP:0200106) | 3.91229633 |
| 6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.91229633 |
| 7 | Gastrointestinal infarctions (HP:0005244) | 3.91190596 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.88278137 |
| 9 | Spontaneous hematomas (HP:0007420) | 3.86876064 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.69810140 |
| 11 | Recurrent skin infections (HP:0001581) | 3.69163673 |
| 12 | Thick nail (HP:0001805) | 3.64569313 |
| 13 | Keratoconjunctivitis sicca (HP:0001097) | 3.63971519 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.61661070 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.40532112 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.40532112 |
| 17 | T lymphocytopenia (HP:0005403) | 3.34211721 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.31162292 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.30053062 |
| 20 | Encephalitis (HP:0002383) | 3.27452289 |
| 21 | Abnormality of T cell number (HP:0011839) | 3.13924508 |
| 22 | Hypochromic microcytic anemia (HP:0004840) | 3.11554571 |
| 23 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.11440753 |
| 24 | Focal motor seizures (HP:0011153) | 3.09464674 |
| 25 | Gingival bleeding (HP:0000225) | 3.08361124 |
| 26 | Chest pain (HP:0100749) | 3.02011516 |
| 27 | Peritonitis (HP:0002586) | 3.01073807 |
| 28 | Fair hair (HP:0002286) | 3.00789257 |
| 29 | Febrile seizures (HP:0002373) | 2.99366915 |
| 30 | Pulmonary embolism (HP:0002204) | 2.99363788 |
| 31 | Submucous cleft hard palate (HP:0000176) | 2.98051436 |
| 32 | Prolonged bleeding time (HP:0003010) | 2.96509656 |
| 33 | Papilledema (HP:0001085) | 2.94743533 |
| 34 | Optic neuritis (HP:0100653) | 2.91702841 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.91702841 |
| 36 | Generalized hypopigmentation of hair (HP:0011358) | 2.91060694 |
| 37 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.90266541 |
| 38 | Recurrent bacterial skin infections (HP:0005406) | 2.86345250 |
| 39 | Testicular atrophy (HP:0000029) | 2.84537860 |
| 40 | Cellulitis (HP:0100658) | 2.84277307 |
| 41 | Vasculitis (HP:0002633) | 2.83029904 |
| 42 | Prostate neoplasm (HP:0100787) | 2.82620697 |
| 43 | Arterial thrombosis (HP:0004420) | 2.82573645 |
| 44 | Eczematoid dermatitis (HP:0000976) | 2.82445531 |
| 45 | Obstructive lung disease (HP:0006536) | 2.82354017 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.82354017 |
| 47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.78438066 |
| 48 | Leukocytosis (HP:0001974) | 2.73848874 |
| 49 | Urticaria (HP:0001025) | 2.71286835 |
| 50 | Hemiplegia (HP:0002301) | 2.69623490 |
| 51 | Subacute progressive viral hepatitis (HP:0006572) | 2.67113486 |
| 52 | Increased IgE level (HP:0003212) | 2.62776371 |
| 53 | Neonatal hypoglycemia (HP:0001998) | 2.62442885 |
| 54 | Fragile nails (HP:0001808) | 2.59769107 |
| 55 | Anhidrosis (HP:0000970) | 2.56748734 |
| 56 | Increased cerebral lipofuscin (HP:0011813) | 2.54984249 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.54400362 |
| 58 | Nephritis (HP:0000123) | 2.50557746 |
| 59 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.47973456 |
| 60 | Amyloidosis (HP:0011034) | 2.47686041 |
| 61 | Episodic fever (HP:0001954) | 2.47376968 |
| 62 | Lip pit (HP:0100267) | 2.45588515 |
| 63 | Plantar hyperkeratosis (HP:0007556) | 2.45544839 |
| 64 | Epistaxis (HP:0000421) | 2.42311885 |
| 65 | Chronic otitis media (HP:0000389) | 2.42084864 |
| 66 | Orchitis (HP:0100796) | 2.40826077 |
| 67 | Microcytic anemia (HP:0001935) | 2.40185122 |
| 68 | Congenital, generalized hypertrichosis (HP:0004540) | 2.39983063 |
| 69 | Hypochromic anemia (HP:0001931) | 2.39706124 |
| 70 | Asymmetric septal hypertrophy (HP:0001670) | 2.39480953 |
| 71 | Abnormal ciliary motility (HP:0012262) | 2.35061588 |
| 72 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.33530031 |
| 73 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.33530031 |
| 74 | Difficulty running (HP:0009046) | 2.30962219 |
| 75 | Milia (HP:0001056) | 2.30284689 |
| 76 | Progressive visual loss (HP:0000529) | 2.30129794 |
| 77 | Gingivitis (HP:0000230) | 2.30059058 |
| 78 | Stomach cancer (HP:0012126) | 2.29888534 |
| 79 | Recurrent viral infections (HP:0004429) | 2.28785514 |
| 80 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.27535891 |
| 81 | Cerebral palsy (HP:0100021) | 2.24980666 |
| 82 | Retinal atrophy (HP:0001105) | 2.23217165 |
| 83 | Periodontitis (HP:0000704) | 2.23068581 |
| 84 | Agitation (HP:0000713) | 2.21970757 |
| 85 | Abnormality of T cells (HP:0002843) | 2.20327040 |
| 86 | Absent eyebrow (HP:0002223) | 2.19943455 |
| 87 | Viral hepatitis (HP:0006562) | 2.19859239 |
| 88 | Broad-based gait (HP:0002136) | 2.17625804 |
| 89 | Exotropia (HP:0000577) | 2.15155434 |
| 90 | Abnormality of the endocardium (HP:0004306) | 2.15084166 |
| 91 | Protruding tongue (HP:0010808) | 2.14407135 |
| 92 | Premature loss of primary teeth (HP:0006323) | 2.14015372 |
| 93 | Anorexia (HP:0002039) | 2.13033508 |
| 94 | Gastrointestinal inflammation (HP:0004386) | 2.12939942 |
| 95 | Macular degeneration (HP:0000608) | 2.11770981 |
| 96 | Distal lower limb muscle weakness (HP:0009053) | 2.11609326 |
| 97 | Hypoplastic nipples (HP:0002557) | 2.11250466 |
| 98 | Congenital stationary night blindness (HP:0007642) | 2.10461683 |
| 99 | Decreased central vision (HP:0007663) | 2.07721867 |
| 100 | Osteomyelitis (HP:0002754) | 2.06129392 |
| 101 | Recurrent sinusitis (HP:0011108) | 2.06081239 |
| 102 | Inflammation of the large intestine (HP:0002037) | 2.05931305 |
| 103 | Gangrene (HP:0100758) | 2.05372740 |
| 104 | Epileptic encephalopathy (HP:0200134) | 2.04694378 |
| 105 | Abnormality of the pleura (HP:0002103) | 2.04204222 |
| 106 | Spondylolisthesis (HP:0003302) | 2.03089369 |
| 107 | Abolished electroretinogram (ERG) (HP:0000550) | 2.02484316 |
| 108 | Ectropion (HP:0000656) | 2.02243410 |
| 109 | Granulocytopenia (HP:0001913) | 2.02133920 |
| 110 | Inappropriate behavior (HP:0000719) | 2.00474184 |
| 111 | Abnormality of the peritoneum (HP:0002585) | 2.00252867 |
| 112 | Meningitis (HP:0001287) | 1.98977338 |
| 113 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.96092691 |
| 114 | Focal seizures (HP:0007359) | 1.94784561 |
| 115 | Disinhibition (HP:0000734) | 1.94638661 |
| 116 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94190627 |
| 117 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94190627 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94190627 |
| 119 | Alopecia of scalp (HP:0002293) | 1.93504815 |
| 120 | Vertigo (HP:0002321) | 1.93399157 |
| 121 | Thrombophlebitis (HP:0004418) | 1.93080705 |
| 122 | Glomerulonephritis (HP:0000099) | 1.92297100 |
| 123 | Chronic hepatic failure (HP:0100626) | 1.92204616 |
| 124 | Sepsis (HP:0100806) | 1.91794529 |
| 125 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88791656 |
| 126 | Amyotrophic lateral sclerosis (HP:0007354) | 1.88730072 |
| 127 | Muscle fiber splitting (HP:0003555) | 1.88283817 |
| 128 | Aplasia cutis congenita (HP:0001057) | 1.88196078 |
| 129 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.87342292 |
| 130 | Eosinophilia (HP:0001880) | 1.87069692 |
| 131 | Abnormal glucose tolerance (HP:0001952) | 1.86710630 |
| 132 | Vitreoretinal degeneration (HP:0000655) | 1.86024767 |
| 133 | Hypohidrosis (HP:0000966) | 1.85607376 |
| 134 | Panhypogammaglobulinemia (HP:0003139) | 1.85280825 |
| 135 | Xerostomia (HP:0000217) | 1.85271705 |
| 136 | Cheilitis (HP:0100825) | 1.85126400 |
| 137 | Inability to walk (HP:0002540) | 1.84479295 |
| 138 | Hemoptysis (HP:0002105) | 1.83331411 |
| 139 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.83085703 |
| 140 | Aplasia of the phalanges of the hand (HP:0009802) | 1.83085703 |
| 141 | Aplasia involving bones of the extremities (HP:0009825) | 1.83085703 |
| 142 | Increased IgM level (HP:0003496) | 1.82399436 |
| 143 | Mediastinal lymphadenopathy (HP:0100721) | 1.81582433 |
| 144 | Palpebral edema (HP:0100540) | 1.80535344 |
| 145 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.80405152 |
| 146 | Abnormality of macular pigmentation (HP:0008002) | 1.79829489 |
| 147 | Dyschromatopsia (HP:0007641) | 1.79735988 |
| 148 | Corneal erosion (HP:0200020) | 1.79687468 |
| 149 | Palmoplantar hyperkeratosis (HP:0000972) | 1.77405431 |
| 150 | Palmar hyperkeratosis (HP:0010765) | 1.77321279 |
| 151 | Abnormality of the fingertips (HP:0001211) | 1.77305909 |
| 152 | Hip dysplasia (HP:0001385) | 1.76889542 |
| 153 | Hematochezia (HP:0002573) | 1.76472997 |
| 154 | Azoospermia (HP:0000027) | 1.75646908 |
| 155 | Systemic lupus erythematosus (HP:0002725) | 1.75530204 |
| 156 | Pustule (HP:0200039) | 1.74769059 |
| 157 | Slow saccadic eye movements (HP:0000514) | 1.74720209 |
| 158 | Papillary thyroid carcinoma (HP:0002895) | 1.74207259 |
| 159 | Absent hand (HP:0004050) | 1.73084160 |
| 160 | Abnormality of salivation (HP:0100755) | 1.71834497 |
| 161 | Onycholysis (HP:0001806) | 1.70837400 |
| 162 | Progressive cerebellar ataxia (HP:0002073) | 1.70019102 |
| 163 | Abnormality of the neuromuscular junction (HP:0003398) | 1.69923996 |
| 164 | Fatigable weakness (HP:0003473) | 1.69923996 |
| 165 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.69520947 |
| 166 | Metaphyseal cupping (HP:0003021) | 1.69229904 |
| 167 | Myositis (HP:0100614) | 1.68962053 |
| 168 | White forelock (HP:0002211) | 1.68156097 |
| 169 | Abnormality of eosinophils (HP:0001879) | 1.68130241 |
| 170 | Attenuation of retinal blood vessels (HP:0007843) | 1.67717265 |
| 171 | Conical tooth (HP:0000698) | 1.67375227 |
| 172 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.67048814 |
| 173 | Keratitis (HP:0000491) | 1.66037109 |
| 174 | Abnormal platelet volume (HP:0011876) | 1.65119101 |
| 175 | Frequent falls (HP:0002359) | 1.63731285 |
| 176 | Lymphopenia (HP:0001888) | 1.61707905 |
| 177 | Alveolar cell carcinoma (HP:0006519) | 1.60813270 |
| 178 | Acne (HP:0001061) | 1.60217517 |
| 179 | Glomerulopathy (HP:0100820) | 1.58662960 |
| 180 | Colitis (HP:0002583) | 1.55688789 |
| 181 | Dysostosis multiplex (HP:0000943) | 1.55124793 |
| 182 | Recurrent bronchitis (HP:0002837) | 1.54598530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.01264308 |
| 2 | AKT3 | 2.90780418 |
| 3 | RIPK4 | 2.73992139 |
| 4 | MAP2K3 | 2.72144688 |
| 5 | INSRR | 2.66680112 |
| 6 | MAP4K1 | 2.57878570 |
| 7 | PDK2 | 2.54202798 |
| 8 | CSK | 2.50177408 |
| 9 | TNIK | 2.09277721 |
| 10 | EPHA4 | 2.06089930 |
| 11 | NTRK3 | 2.03904071 |
| 12 | ZAK | 2.03627834 |
| 13 | SIK2 | 2.00073650 |
| 14 | IRAK4 | 1.98674525 |
| 15 | GRK1 | 1.96528080 |
| 16 | MARK1 | 1.87862007 |
| 17 | NEK6 | 1.82462731 |
| 18 | ZAP70 | 1.81532794 |
| 19 | STK16 | 1.68321177 |
| 20 | IRAK3 | 1.66856539 |
| 21 | GRK6 | 1.64076695 |
| 22 | SIK3 | 1.63067792 |
| 23 | MAPK13 | 1.63057588 |
| 24 | CDK3 | 1.61960893 |
| 25 | TNK2 | 1.59786709 |
| 26 | YES1 | 1.56749926 |
| 27 | MAP3K6 | 1.52562738 |
| 28 | TAOK3 | 1.51443833 |
| 29 | MAP3K14 | 1.51318914 |
| 30 | PINK1 | 1.50515831 |
| 31 | GRK7 | 1.48686774 |
| 32 | FGFR3 | 1.47920609 |
| 33 | TAOK1 | 1.47784041 |
| 34 | MAPK15 | 1.46249962 |
| 35 | EPHB1 | 1.45731932 |
| 36 | JAK2 | 1.41944237 |
| 37 | JAK3 | 1.40124474 |
| 38 | BMPR2 | 1.38748842 |
| 39 | MAP3K12 | 1.33672668 |
| 40 | MAPK7 | 1.28645189 |
| 41 | MAP2K6 | 1.27681696 |
| 42 | KSR2 | 1.27115610 |
| 43 | FES | 1.26474479 |
| 44 | MAP3K7 | 1.20198587 |
| 45 | MAPK12 | 1.19869167 |
| 46 | TEC | 1.17967485 |
| 47 | MAP3K13 | 1.17467340 |
| 48 | ERBB3 | 1.16021119 |
| 49 | PKN1 | 1.13734504 |
| 50 | SGK2 | 1.09094403 |
| 51 | IRAK2 | 1.08919588 |
| 52 | NEK1 | 1.08276187 |
| 53 | PTK2B | 1.06110902 |
| 54 | CSF1R | 1.05128820 |
| 55 | FRK | 1.04646118 |
| 56 | NTRK2 | 1.04396364 |
| 57 | ADRBK2 | 1.03894613 |
| 58 | NUAK1 | 1.03860324 |
| 59 | ITK | 1.03381040 |
| 60 | TGFBR2 | 1.03234255 |
| 61 | MAP2K7 | 1.03141693 |
| 62 | MAP3K2 | 0.98323781 |
| 63 | LCK | 0.96662753 |
| 64 | MAPKAPK5 | 0.94755463 |
| 65 | MUSK | 0.94077300 |
| 66 | KSR1 | 0.92967649 |
| 67 | IKBKB | 0.91468573 |
| 68 | MAP3K1 | 0.90810009 |
| 69 | BLK | 0.90018514 |
| 70 | STK11 | 0.89237402 |
| 71 | IRAK1 | 0.89061243 |
| 72 | TYK2 | 0.88997841 |
| 73 | TXK | 0.87170296 |
| 74 | WNK1 | 0.85333330 |
| 75 | HCK | 0.85056139 |
| 76 | MARK3 | 0.84222778 |
| 77 | NLK | 0.84026994 |
| 78 | PRKCE | 0.81545808 |
| 79 | MATK | 0.80484441 |
| 80 | SYK | 0.80338420 |
| 81 | HIPK2 | 0.79277972 |
| 82 | RET | 0.77283790 |
| 83 | ERN1 | 0.77137323 |
| 84 | MAP3K5 | 0.76252311 |
| 85 | PTK6 | 0.75517371 |
| 86 | DYRK1B | 0.74571929 |
| 87 | TBK1 | 0.71682725 |
| 88 | EPHB2 | 0.71030642 |
| 89 | RAF1 | 0.70247437 |
| 90 | PRPF4B | 0.69741291 |
| 91 | FGR | 0.66631965 |
| 92 | EIF2AK2 | 0.66591741 |
| 93 | PIK3CG | 0.65445034 |
| 94 | ERBB2 | 0.63732004 |
| 95 | DAPK2 | 0.61801481 |
| 96 | CLK1 | 0.61278031 |
| 97 | CAMK2A | 0.61082125 |
| 98 | BRD4 | 0.60639011 |
| 99 | BMPR1B | 0.60207383 |
| 100 | IKBKE | 0.59537484 |
| 101 | KIT | 0.59330603 |
| 102 | SGK494 | 0.59240977 |
| 103 | SGK223 | 0.59240977 |
| 104 | FYN | 0.58941702 |
| 105 | PHKG1 | 0.58901873 |
| 106 | PHKG2 | 0.58901873 |
| 107 | FGFR2 | 0.58603434 |
| 108 | CAMK1D | 0.58109047 |
| 109 | PDPK1 | 0.58057258 |
| 110 | MAP3K11 | 0.57867112 |
| 111 | CAMK4 | 0.56630004 |
| 112 | CCNB1 | 0.56447574 |
| 113 | LYN | 0.55875896 |
| 114 | MARK2 | 0.55361873 |
| 115 | SGK1 | 0.54797841 |
| 116 | PRKD1 | 0.53997709 |
| 117 | BTK | 0.52366103 |
| 118 | PDK1 | 0.52175226 |
| 119 | SGK3 | 0.51608492 |
| 120 | RPS6KA2 | 0.51330264 |
| 121 | TRPM7 | 0.50648357 |
| 122 | CAMK1G | 0.50450511 |
| 123 | EPHA3 | 0.50180004 |
| 124 | CAMK1 | 0.48765981 |
| 125 | PRKCQ | 0.47763154 |
| 126 | LRRK2 | 0.47657302 |
| 127 | CAMKK2 | 0.47394586 |
| 128 | ACVR1B | 0.47173586 |
| 129 | DYRK1A | 0.46165809 |
| 130 | NEK9 | 0.45841978 |
| 131 | PRKD2 | 0.44778285 |
| 132 | STK24 | 0.44678621 |
| 133 | FER | 0.44466181 |
| 134 | DYRK3 | 0.44311597 |
| 135 | PKN2 | 0.44212855 |
| 136 | MKNK2 | 0.43935308 |
| 137 | MAP2K4 | 0.42994324 |
| 138 | MST1R | 0.42879539 |
| 139 | CDK5 | 0.42306193 |
| 140 | STK38 | 0.40486826 |
| 141 | MAP3K3 | 0.40007194 |
| 142 | CDK6 | 0.39876695 |
| 143 | STK10 | 0.38901483 |
| 144 | PRKG1 | 0.38528475 |
| 145 | PRKAA2 | 0.38125455 |
| 146 | JAK1 | 0.38032354 |
| 147 | GRK5 | 0.37939509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.41139793 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.20322785 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 2.07160825 |
| 4 | Morphine addiction_Homo sapiens_hsa05032 | 1.84240273 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 1.77726904 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.70642664 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.69799392 |
| 8 | Taste transduction_Homo sapiens_hsa04742 | 1.63922430 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.57474561 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.56221529 |
| 11 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.54103271 |
| 12 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53715642 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.46658650 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46194539 |
| 15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.45687808 |
| 16 | ABC transporters_Homo sapiens_hsa02010 | 1.45225027 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.42236071 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.40497118 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38752240 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38144325 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.34435013 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.32958232 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.32670872 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.32054045 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.31134170 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.30595664 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28542676 |
| 28 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27943428 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.27492924 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.27119312 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.25152331 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.24887824 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.24439914 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23687305 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.23344761 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.23002345 |
| 37 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.22145205 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.21319515 |
| 39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20025202 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19047315 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.19004372 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18220071 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17602695 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15700549 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.15673931 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15054557 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14405034 |
| 48 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.11803361 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11746739 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08775192 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08535869 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07125978 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.07047211 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.04483297 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 1.03949804 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03895319 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 1.03319638 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.02079831 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 1.00471719 |
| 60 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.00408707 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00322913 |
| 62 | Axon guidance_Homo sapiens_hsa04360 | 1.00261370 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99592971 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98531209 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98276436 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98028838 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98028225 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97638026 |
| 69 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97048993 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94119735 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.93554723 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93440225 |
| 73 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93236833 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92689017 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91541208 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91050022 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.90569233 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90320045 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88561731 |
| 80 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88463854 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87367156 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86321221 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86166790 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.85943267 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85656895 |
| 86 | Long-term depression_Homo sapiens_hsa04730 | 0.85468220 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84637521 |
| 88 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.84524517 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.84372746 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82449474 |
| 91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81216073 |
| 92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80343493 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79524432 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79422904 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.78938064 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78365412 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77179894 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.75407614 |
| 99 | Tuberculosis_Homo sapiens_hsa05152 | 0.75213752 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74185596 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72758981 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71881805 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70465150 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70267103 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.68934265 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68839549 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67689379 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67561350 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67302732 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67264924 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67099919 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66603762 |
| 113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66603376 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66000408 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.65273456 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64599800 |
| 117 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64370899 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61516226 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.59820203 |
| 120 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.59514501 |
| 121 | Apoptosis_Homo sapiens_hsa04210 | 0.58944871 |
| 122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58721308 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58714563 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58243476 |
| 125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58076653 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58042710 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57928939 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.57899162 |
| 129 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57726686 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56000322 |
| 131 | Asthma_Homo sapiens_hsa05310 | 0.55889344 |
| 132 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55615671 |
| 133 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55042709 |
| 134 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53479082 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53390862 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53292216 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53175385 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.52634987 |
| 139 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51661604 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.51297947 |
| 141 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49289754 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49227536 |
| 143 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48257214 |
| 144 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48131632 |
| 145 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48102232 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46962804 |
| 147 | Measles_Homo sapiens_hsa05162 | 0.46884957 |
| 148 | Hepatitis C_Homo sapiens_hsa05160 | 0.46705254 |

